Institutionalizing postpartum intrauterine device (IUD) services in Sri Lanka, Tanzania, and Nepal: Study protocol for a cluster-randomized stepped-wedge trial

BMC Pregnancy and Childbirth

Volumn 16, Issue 1, 2016, Pages

  Canning, David ^a   Shah, Iqbal H ^a   Pearson, Erin ^a   Pradhan, Elina ^a   Karra, Mahesh ^a   Senderowicz, Leigh ^a   Bärnighausen, Till ^a   Spiegelman, Donna ^a   Langer, Ana ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Impact evaluation; IUD; Postpartum contraception

Indexed keywords

ARTICLE; CHILDBIRTH; CLINICAL PROTOCOL; CLUSTER ANALYSIS; CONTROLLED STUDY; FEMALE; HEALTH CARE FACILITY; HOSPITAL SERVICE; HUMAN; INSTITUTIONALIZATION; INTRAUTERINE CONTRACEPTIVE DEVICE; NEPAL; OUTCOME ASSESSMENT; POSTPARTUM INTRAUTERINE DEVICE; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL; REPRODUCTIVE HEALTH; SRI LANKA; TANZANIA; THERAPY EFFECT; ADULT; CONTRACEPTION; FAMILY PLANNING; HEALTH CARE PLANNING; HOSPITAL; ORGANIZATION AND MANAGEMENT; ORGANIZATIONAL POLICY; POSTNATAL CARE; PREGNANCY; PROCEDURES; PROGRAM EVALUATION;

ADULT; CLINICAL PROTOCOLS; CLUSTER ANALYSIS; CONTRACEPTION; FAMILY PLANNING SERVICES; FEMALE; HEALTH PLAN IMPLEMENTATION; HOSPITALS; HUMANS; INTRAUTERINE DEVICES; NEPAL; ORGANIZATIONAL POLICY; POSTNATAL CARE; PREGNANCY; PROGRAM EVALUATION; SRI LANKA; TANZANIA;

EID: 84997079802     PISSN: None     EISSN: 14712393     Source Type: Journal    
DOI: 10.1186/s12884-016-1160-0     Document Type: Article

References (23)

1. Kapp N, Curtis KM. Intrauterine device insertion during the postpartum period: a systematic review. Contraception. 2009;80:327-36.
2. Rossier C, Bradley SEK, Ross J, Winfrey W. Reassessing Unmet Need for Family Planning in the Postpartum Period. Stud Fam Plann. 2015;46(4):355-67.
3. Winfrey W, Kshitiz R. Use of Family Planning in Postpartum Period. 2014, 36.
4. World Health Organization (WHO). Medical Eligibility Criteria for Contraceptive use: Fourth Edition, 2009. 2010.
5. Grimes DA, Lopez LM, Schulz KF. Van Vilet HAAM. Stanwood NL: Immediate post-partum insertion of intrauterine devices. Cochrane Database of Systematic Reviews; 2010 (5).
6. Eroğlu K, Akkuzu G, Vural G, Dilbaz B, Akin A, Taşkin L, Haberal A. Comparison of efficacy and complications of IUD insertion in immediate postplacenta/early postpartum period with interval period: 1 year follow-up. Contraception. 2006;74(5):376-81.
7. Arrowsmith ME, Aicken CR, Saxena S, Majeed A. Strategies for improving the acceptability and acceptance of the copper intrauterine device. Cochrane Database Syst Rev. 2012;(3):1-40. Art. No.: CD008896.
8. Bryant AG, Kamanga G, Stuart GS, Haddad LB, Meguid T, Mhango C. Immediate postpartum versus 6-week postpartum intrauterine device insertion: a feasibility study of a randomized controlled trial. Afr J Reprod Health. 2013;17(2):72-9.
9. Mohamed SA, Kamel MA, Shaaban OM, Salem HT. Acceptability for the use of postpartum intrauterine contraceptive devices: assiut experience. Med Prininciples Pract. 2003;12:170-5.
10. McKaig C, Blanchard H. The IUD: A contraceptive option for postpartum and postabortion women. 2006.
11. Van Kets H, Kleinhout J, Osler M, Parewijck W, Zighelboim I, Tatum HJ. Clinical experience with the Gyne-T 380 postpartum intrauterine device. Fertil Steril. 1991;55(6):1144-9.
12. Tatum HJ, Beltran RS, Ramos R, Van Kets H, Sivin I, Schmidt FH. Immediate postplacental insertion of GYNE-T 380 and GYNE-T 380 Postpartum intrauterine contraceptive devices: Randomized study. Obstet Gynecol. 1996;175(5):1231-5.
13. Hussey MA, Hughes JP. Design and analysis of the stepped wedge cluster randomized trials. Contemp Clin Trials. 2007;28(2):182-91.
14. Pagel C, Prost A, Lewycka S, Das S, Colbourn T, Mahapatra R, Azad K, Costello A, Osrin D. Intracluster correlation coefficients and coefficients of variation for perinatal outcomes from five cluster-randomised controlled trials in low and middle-income countries: results and methodological implications. Trials. 2011;12:151.
15. Ali MM, Sadler RK, Cleland J, Ngo TD, Shah IH. Long-term contraceptive protection, discontinuation and switching behaviour: intrauterine device (IUD) use dynamics in 14 developing countries. 2011.
16. Family Health Bureau Minstry of Health, Sri Lanka. Annual Report on Family Health 2012. 2012
17. Ministry of Health and Population (MOHP). Nepal Demographic and Health Survey 2011. Nepal: New ERA, ICF International Inc; 2012.
18. Govindarajulu US, Spiegelman D, Thurston SW, Ganguli B, Eisen EA. Comparing smoothing techniques in Cox models for exposure-response relationships. Stat Med. 2007;26(20):3735-52.
19. Hernan MA, Brumback B, Robins JM. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology. 2000;11(5):561-70.
20. Rotnitzky A, Robins JM. Semiparametric regression estimation in the presence of dependent censoring. Biometrika. 1995;82(4):805-20.
21. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-88.
22. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539-58.
23. Takkouche B, Cadarso-Suarez C, Spiegelman D. Evaluation of old and new tests of heterogeneity in epidemiologic meta-analysis. Am J Epidemiol. 1999;150(2):206-15.